Matinas Biopharma (MTNB) vs Silo Pharma (SILO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Silo Pharma is the larger company by market cap ($2.9 million vs $2.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | MTNB | SILO |
|---|---|---|
| Share price | $2.75 | $1.41 |
| Market cap | $2.69M | $2.90M |
| 1-day change | -0.72% | -2.08% |
| EPS (TTM) | $-17.55 | $-4.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $28.95 | $10.44 |
| 52-week low | $2.27 | $1.30 |
| Distance from 52-week high | -90.50% | -86.49% |
| Average volume | 405.99K | 114.43K |
| Shares outstanding | 979.52K | 2.05M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
MTNB vs SILO FAQ
Which is bigger, Matinas Biopharma or Silo Pharma?
Silo Pharma (SILO) is larger, with a market capitalization of $2.90M compared with $2.69M for Matinas Biopharma (MTNB).
Are Matinas Biopharma and Silo Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.